Journal article icon

Journal article

Treatment of CIDP

Abstract:

Chronic inflammatory demyelinating polyneuropathy is a disabling but treatable disorder. However, misdiagnosis is common, and it can be difficult to optimise its treatment. Various agents are used both for first and second line. First-line options are intravenous immunoglobulin, corticosteroids and plasma exchange. Second-line therapies may be introduced as steroid-sparing agents or as more potent escalation therapy. It is also important to consider symptomatic treatment of neuropathic pain a...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/pn-2021-002991

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Oxford college:
Exeter College
Role:
Author
ORCID:
0000-0003-2039-3457
Publisher:
BMJ Publishing Group
Journal:
Practical Neurology More from this journal
Volume:
23
Issue:
1
Pages:
46-53
Place of publication:
England
Publication date:
2022-09-15
Acceptance date:
2022-07-10
DOI:
EISSN:
1474-7766
ISSN:
1474-7758
Pmid:
36109154
Language:
English
Keywords:
Pubs id:
1279840
Local pid:
pubs:1279840
Deposit date:
2023-02-02

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP